Scholarlink

<p>The transferrin receptor (TfR) is a transmembrane glycoprotein that plays a crucial role in iron uptake. TfR is often overexpressed in malignant cancer cells, enabling rapid proliferation. Given the significance of iron uptake in various disease states, blocking transferrin (Tf)-mediated iron uptake could serve as an effective therapeutic strategy. Tf-TfR endocytosis is facilitated by the multimeric AP2 complex through a tyrosine motif on TfR, which is recognized by the AP2 mu subunit. In the present study, fluorescently labeled transferrin was employed to monitor cellular endocytosis in the presence of lipidated decoy peptides containing endocytic motifs that are recognized by the AP2 complex. The results demonstrated that transferrin endocytosis is inhibited when in the presence of a peptide that specifically targets the mu subunit, but not with a peptide that targets the sigma subunit. These findings suggest that Tf-TfR endocytosis can be selectively inhibited through the selective inhibition of the AP2 mu subunit, indicating potential as a novel strategy for inhibiting iron influx in malignant cancer cells.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A small lipidated peptide that inhibits transferrin uptake

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月27日

查看全文
  • Richard Nicosia,
  • Arin Bhattacharjee

摘要

The transferrin receptor (TfR) is a transmembrane glycoprotein that plays a crucial role in iron uptake. TfR is often overexpressed in malignant cancer cells, enabling rapid proliferation. Given the significance of iron uptake in various disease states, blocking transferrin (Tf)-mediated iron uptake could serve as an effective therapeutic strategy. Tf-TfR endocytosis is facilitated by the multimeric AP2 complex through a tyrosine motif on TfR, which is recognized by the AP2 mu subunit. In the present study, fluorescently labeled transferrin was employed to monitor cellular endocytosis in the presence of lipidated decoy peptides containing endocytic motifs that are recognized by the AP2 complex. The results demonstrated that transferrin endocytosis is inhibited when in the presence of a peptide that specifically targets the mu subunit, but not with a peptide that targets the sigma subunit. These findings suggest that Tf-TfR endocytosis can be selectively inhibited through the selective inhibition of the AP2 mu subunit, indicating potential as a novel strategy for inhibiting iron influx in malignant cancer cells.